LVW Advisors »

Nektar Therapeutics shares owned by LVW Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by LVW Advisors from 13F filings

Historical chart of LVW Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by LVW Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by LVW Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $207k 3.4k 60.55
2026-06-30 $211k 3.0k 69.81
2026-03-31 $217k 3.0k 71.95

More positions owned by LVW Advisors

Spdr Series Trust St Str P500etf (SPYM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Vanguard Bd Index Fds Intermed Term (BIV)
Apple (AAPL)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Capital Group Gbl Growth Eqt Shs Creat Unit (CGGO)
Schwab Strategic Tr Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Capital Group International SHS (CGIE)
Ishares Tr Shrt Nat Mun Etf (SUB)
Vanguard Index Fds Mrngstr Grwt Etf (VUG)
Microsoft Corporation (MSFT)
Ab Active Etfs Tax Aw Inter Etf (TAFM)

View all positions for LVW Advisors

Top funds holding Nektar Therapeutics

FMR
Two Seas Capital
BlackRock
BVF
Susquehanna International
Vanguard Capital Management
Two Sigma Investments
Vestal Point Capital
State Street Corporation
Geode Capital Management
Prosight Management
Armistice Capital
Millennium Management
Gilder, Gagnon, Howe & Co
Citadel Advisors

View all funds holding Nektar Therapeutics